Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-31

Clinical Trial Update: Effect of Minocycline on Delirium Incidence in Critically Ill Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether minocycline affects delirium incidence in critically ill patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Conditions: Delirium, Coma | Phase 2 | Status: COMPLETED